In the words of Daughter/Wife Unwanted Ivanka:
“Congratulations @BorisJohnson on becoming the next Prime Minister of the United Kingston.” Yeah, she tweeted that.
(Click on image for larger version)
Well, kids, I am sure that you’ve heard about the New York Times op-ed written by someone only identified as a “senior official in the Trump administration.” It’s titled:
I Am Part of the Resistance Inside the Trump Administration
I work for the president but like-minded colleagues and I have vowed to thwart parts of his agenda and his worst inclinations.
Who can it be? A man, a woman, one person, more than one? A real “resister” or someone who thinks this might help the Rethugs in the midterm elections? Damned if I know! But it’s so much fun trying to guess.
It’s difficult to imagine a worse day in the presidency of Donald Trump than Tuesday, when two gripping legal dramas, one involving his former campaign chairman, Paul Manafort, and the other embroiling his longtime lawyer, Michael Cohen, collided in a surreal split screen crescendo.
From The Mercury News:
While most of President Donald Trump’s offspring and their spouses have been mired in scandal or investigations, or have just been the butt of late-night jokes (see: Eric and Tiffany), Eric Trump’s wife Lara Trump has managed to glide above the fray.
That was until Thursday when former White House aide Omarosa Manigault Newman released a secret recording of a conversation with Lara Trump. Manigault Newman played the recording on MSNBC to bolster her contention that Trump’s loyal daughter-in-law tried to buy her silence after she was from the White House staff by offering her a $15,000-a-month contract to work in his re-election campaign.
Rep. Chris Collins‘ son and his son’s fiancee bought shares of an Australian biotech company just days before dumping the shares after the New York Republican allegedly tipped his son off about a failed clinical drug trial in a phone call from the White House lawn, the Securities and Exchange Commission said in a complaint.
Collins’ son, Cameron Collins, and the son’s accountant fiancee, Lauren Zarsky, had purchased the stock of Innate Immunotherapeutics in June 2017 because they believed — mistakenly, it turned out — that the trial of the company’s multiple sclerosis treatment would yield positive results, the SEC said in its complaint.
Click on image for larger version